MY ACCOUNT | NEWSLETTER |

Sanfer celebrates its 80 years facing the challenges of the future with the illusion of the first day


With 17 manufacturing centers located in Mexico and Latin America, Laboratorios Sanfer is a multinational with a global presence that celebrates its 80th anniversary; in 1941, Ramón Santoveña and Celestino Fernández Valle merged the pharmaceutical companies they ran separately, thus giving rise to the brand Sanfer.

More than 7,500 employees and 1,400 sales representatives have consolidated Sanfer as the pharmaceutical company with the greatest expansion in Latin America through the acquisition and creation of new companies in 26 countries, with 32 distribution centers and a presence in 41 countries around the world.

Currently, Sanfer has more than 250 brands that cover the main therapeutic classes on the market, and that respond to the objective of providing people with a quality of life and a future based on science and technology. In addition to human and animal health, the Sanfer group is also present in cosmetics and cleaning.

In its line of animal health Sanfer offers innovative and quality products with a wide portfolio of products (biological, pharmacological, zoosanitary, nutritional additives, etc.) research, diagnostic and avian genetics services.

The importance of the One Health approach

In its eight-decade history, Sanfer has always evolved and innovated to meet the health needs of the population. This has meant that the company has long understood the importance of the One Health approach, and that from that One Health perspective, they understand animal and human health as one that has to go in only one direction. Thus, its goal is to maintain its national and international reputation by manufacturing and offering quality products for human and animal health.

Sanfer keeps alive their initial impulse to provide solutions that improve people's quality of life. Today, 80 years after his birth, Sanfer is ready to face the challenges of the future like the first day.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

One Committed and Caring NC State Veterinary Student, So Many Choices

Like1
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top